Patents by Inventor Jeanne Tran Van Nhieu

Jeanne Tran Van Nhieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
    Patent number: 8575125
    Abstract: The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: November 5, 2013
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
    Patent number: 8236763
    Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: August 7, 2012
    Assignees: Inserm, Sanofi-Aventis
    Inventors: Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu
  • SELECTIVE INHIBITORS OF CB2 RECEPTOR EXPRESSION AND/OR ACTIVITY FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
    Publication number: 20120115931
    Abstract: The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 10, 2012
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
    Patent number: 8084422
    Abstract: The invention relates to the use of a selective inhibitor of CB2 receptor expression and/or for the manufacture of a medicament indented for the treatment and/or the prevention of obesity and obesity-related disorders.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 27, 2011
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver
    Patent number: 7906156
    Abstract: Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has liver fibrosis.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: March 15, 2011
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat, Sophie Lotersztajn
  • SELECTIVE INHIBITORS OF CB2 RECEPTOR EXPRESSION AND/OR ACTIVITY FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
    Publication number: 20100056758
    Abstract: The invention relates to the use of a selective inhibitor of CB2 receptor expression and/or for the manufacture of a medicament indented for the treatment and/or the prevention of obesity and obesity-related disorders.
    Type: Application
    Filed: April 4, 2008
    Publication date: March 4, 2010
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Syivie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • CB2 RECEPTORS BLOCKS ACCUMULATION OF HUMAN HEPATIC MYOFIBROBLASTS: A NOVEL ANTIFIBROGENIC PATHWAY IN THE LIVER
    Publication number: 20090221692
    Abstract: Methods for treating diseases of the livers mediated by CB2 receptors are described. The methods may include administering an effective amount of a cannabinoid, an agent that activates a CB2 receptor, a composition that includes a non-selective agonist of CB2 and a selective antagonist of CB1, a composition that includes an agonist of CB2 receptors, and/or a composition that includes an up-regulator of CB2 receptors to a patient who has liver fibrosis.
    Type: Application
    Filed: February 26, 2009
    Publication date: September 3, 2009
    Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: PASCALE GRENARD, BORIS JULIEN, JEANNE TRAN VAN NHIEU, ARIANE MALLAT, SOPHIE LOTERSZTAJN
  • CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver
    Patent number: 7320805
    Abstract: Methods and compositions for treating diseases mediated by CB2 receptors are disclosed, including fibrosis associated with liver injury.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: January 22, 2008
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Pascale Grenard, Boris Julien, Jeanne Tran Van Nhieu, Ariane Mallat, Sophie Lotersztajn